Florbetaben (BAY94-9172)

DRUG4 trials

Sponsors

Life Molecular Imaging SA

Conditions

Alzheimer DiseaseAmyloid Beta-ProteinAmyloid Beta-proteinDown Syndrome

Phase 1

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

CompletedNCT01138111

Life Molecular Imaging SAAlzheimer Disease, Amyloid Beta-Protein

Start: 2008-06-30End: 2011-12-31Updated: 2014-06-25

Phase 2

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

CompletedNCT00750282

Life Molecular Imaging SAAlzheimer Disease, Amyloid Beta-Protein

Start: 2008-08-31End: 2010-11-30Updated: 2014-07-24

Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

CompletedNCT00928304

Life Molecular Imaging SAAmyloid Beta-protein, Down Syndrome

Start: 2009-06-30End: 2011-01-31Updated: 2014-03-05

Phase 3

Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology

CompletedNCT01020838

Life Molecular Imaging SAAlzheimer Disease

Start: 2009-11-30End: 2013-12-31Updated: 2016-05-27

Related Papers

Early detection of amyloid load using <sup>18</sup>F-florbetaben PET.

2021-03-2744 citations

Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study.

2016-01-2879 citations

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Alzheimer s & Dementia2015-03-27577 citations

Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study

Journal of Neurology Neurosurgery & Psychiatry2014-06-2699 citations

Negative Florbetaben PET Scan Excludes the Presence of Amyloid Pathology

MD Conference Express2014-06-01

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

2011-04-08443 citations